Sentence examples for immunodeficiency for from inspiring English sources

Thus, ketamine may induce a transient immunodeficiency for about 3 hr, that in the case of V. cholerae, is absolutely essential for mice to be susceptible to small intestine colonization.

Potential explanatory variables included age group, gender, immunodeficiency for age, history and duration on ART, malnutrition history, orphan status, cotrimoxazole prophylaxis and country.

Thus, the adjusted model included only the following covariates: ART (forced as the main explanatory variable), cotrimoxazole and severe immunodeficiency for age.

HAART has been the standard of care for patients with a certain degree of immunodeficiency for more than a decade, however, and it was impossible to meet this goal.

The IR in children with severe immunodeficiency for age was 29.4/100 CY (95 % CI: 3.6-55.2) and 17.0/100 CY (95 % CI: 11.7-22.3) in those without severe immunodeficiency.

CD4 was used in percentage for children < 5 years and in cells/μL for children ≥ 5 years and we defined immunodeficiency for age according to the 2006 WHO definitions [ 16].

Determination of the serum level of immunoglobulins is very important for the diagnosis of autoimmune and immunodeficiency diseases, for example, X-linked agammaglobulinemia and common variable immunodeficiency syndrome [1, 2].

Strategies of lipopolysaccharide (LPS) stimulation with or without previous toll-like receptor 4 (TLR4) blocking were pursued to investigate the mechanism of LPS-induced preterm delivery in syngeneically impregnated BALB/c and non-obese diabetic (NOD)/LtSz-scid/scid (NOD/SCID [severe combined immunodeficiency] for short) mice.

Moreover, the proportion of children with low antibody levels to EPI vaccines differed according to the degree of immunodeficiency, except for the tetanus and the poliovirus type 3 vaccines (Table 2).

The French DEFI study group delineated a CVID subgroup with clinically relevant T-cell insufficiency and coined the term 'late onset combined immunodeficiency' (LOCID) for these patients [ 37].

The pharmacoenhancement of plasma concentrations of protease inhibitors by coadministration of so-called boosters has been an integral part of antiretroviral therapy for human immunodeficiency virus (HIV) for 1.5 decades.